Oxalic Acid

Oxalic Acid

SCHEMBL1229650

CCN(CC)CCNc1cccc2ccccc12.O=C(O)C(=O)O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 1/20 0.44
OPRM1 known ✓ P35372 1/20 0.44
CHEK1 O14757 1/20 0.58
PIM1 P11309 1/20 0.58
IDO1 P14902 1/20 0.58
LTK P29376 1/20 0.58
LIMK1 P53667 1/20 0.58
CLK4 Q9HAZ1 1/20 0.58
CA12 O43570 2/20 0.56
CA4 P22748 2/20 0.56
CA7 P43166 2/20 0.56
CA9 Q16790 2/20 0.56
CA14 Q9ULX7 2/20 0.56
KDM4E B2RXH2 4/20 0.50
RAD52 P43351 2/20 0.49
ALDH1A1 P00352 3/20 0.49
TSHR P16473 2/20 0.49
HSD17B10 Q99714 2/20 0.49
HPGD P15428 2/20 0.49
MAPT P10636 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2781417 0.91 CHEK1 (0.63) CHEK1PIM1IDO1LTKLIMK1
SCHEMBL8379135 0.82 TSHR (0.62) CHEK1PIM1IDO1LTKLIMK1
Oxalic Acid SCHEMBL11348295 0.78 CA12 (0.81) IDO1CA12CA4CA7CA9
Oxalic Acid SCHEMBL27888753 0.78 CA12 (0.81) IDO1CA12CA4CA7CA9
Oxalic Acid SCHEMBL6473515 0.77 CA12 (0.78) IDO1CA12CA4CA7CA9
SCHEMBL11669132 0.76 CA12 (0.61) CA12CA4CA7CA9CA14
Oxalic Acid SCHEMBL5572818 0.74 KDM4E (0.52) KDM4EALDH1A1TSHRHPGDKMT2A
Hydrochloric Acid SCHEMBL11668772 0.74 ALDH1A1 (0.62) CA12CA4CA7CA9CA14
Hydrochloric Acid SCHEMBL9850535 0.74 ALDH1A1 (0.62) CHEK1PIM1IDO1LTKLIMK1
SCHEMBL9016205 0.74 CA12 (0.62) CA12CA4CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462441-B1 METHOD OF DETECTING OXIDES OF NITROGEN 3M INNOVATIVE PROPERTIES CO (US) 2016-11-23 EP disclosed
US-20150072966-A1 METHOD OF PROMOTING WOUND HEALING 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-03-12 US disclosed
EP-2820428-A1 METHOD OF PROMOTING WOUND HEALING 3M Innovative Properties Company (US) 2015-01-07 EP disclosed
US-8617897-B2 Method of detecting oxides of nitrogen 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-12-31 US disclosed
WO-2013130687-A1 METHOD OF PROMOTING WOUND HEALING 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-09-06 WO disclosed
US-8460863-B2 Dry stick device and method for determining an analyte in a sample LATTEC I/S (DK) 2013-06-11 US disclosed
EP-1982183-B9 DRY STICK DEVICE AND METHOD FOR DETERMINING AN ANALYTE IN A SAMPLE LATTEC I S (DK) 2012-12-12 EP disclosed
US-20120308992-A1 DRY STICK DEVICE AND METHOD FOR DETERMINING AN ANALYTE IN A SAMPLE LATTEC I/S 2012-12-06 US disclosed
EP-1982183-B1 DRY STICK DEVICE AND METHOD FOR DETERMINING AN ANALYTE IN A SAMPLE LATTEC I S (DK) 2012-06-27 EP disclosed
EP-2462441-A1 METHOD OF DETECTING OXIDES OF NITROGEN 3M Innovative Properties Company (US) 2012-06-13 EP disclosed
US-8198073-B2 Dry stick device and method for determining an analyte in a sample LATTEC I/S (DK) 2012-06-12 US disclosed
US-20120129266-A1 METHOD OF DETECTING OXIDES OF NITROGEN 3M INNOVATIVE PROPERTIES COMPANY 2012-05-24 US disclosed
WO-2011017317-A1 METHOD OF DETECTING OXIDES OF NITROGEN 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-02-10 WO disclosed
US-20100233723-A1 DRY STICK DEVICE AND METHOD FOR DETERMINING AN ANALYTE IN A SAMPLE LATTEC I/S (DK) 2010-09-16 US disclosed
EP-1982183-A1 DRY STICK DEVICE AND METHOD FOR DETERMINING AN ANALYTE IN A SAMPLE Lattec I/S (DK) 2008-10-22 EP disclosed
WO-2007082545-A1 DRY STICK DEVICE AND METHOD FOR DETERMINING AN ANALYTE IN A SAMPLE LATTEC I/S (DK) 2007-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150072966-A1 METHOD OF PROMOTING WOUND HEALING NOS3, NOS1, NOS2 SLC6A4 3224/4885OPRM1 526/4885CHEK1 4628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.